Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: MODERNA BIOPHARMA CANADA CORPORATION
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Approved | 02561433 | MODERNA BIOPHARMA CANADA CORPORATION | MNEXSPIKE | Human | Yes | SCHEDULE D | 1 | *SARSCOV2 S-PROTEIN NTD-RBD SUBDOMAINS MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA | 10 MCG / 0.2 ML |
| Approved | 02552914 | MODERNA BIOPHARMA CANADA CORPORATION | MRESVIA | Human | Yes | SCHEDULE D | 1 | *RSV F-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA | 50 MCG / 0.5 ML |
| Cancelled Post Market | 02510014 | MODERNA BIOPHARMA CANADA CORPORATION | SPIKEVAX | Human | Yes | SCHEDULE D | 1 | ELASOMERAN | 0.2 MG / ML |
| Cancelled Post Market | 02527685 | MODERNA BIOPHARMA CANADA CORPORATION | SPIKEVAX | Human | Yes | SCHEDULE D | 1 | ELASOMERAN | 0.1 MG / ML |
| Marketed | 02541270 | MODERNA BIOPHARMA CANADA CORPORATION | SPIKEVAX | Human | Yes | SCHEDULE D | 1 | *SARSCOV2 S-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA | 0.1 MG / ML |
| Marketed | 02557770 | MODERNA BIOPHARMA CANADA CORPORATION | SPIKEVAX | Human | Yes | SCHEDULE D | 1 | *SARSCOV2 S-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA | 50 MCG / 0.5 ML |
| Cancelled Post Market | 02530252 | MODERNA BIOPHARMA CANADA CORPORATION | SPIKEVAX BIVALENT | Human | Yes | SCHEDULE D | 2 | ELASOMERAN | 0.05 MG / ML |
| Cancelled Post Market | 02532352 | MODERNA BIOPHARMA CANADA CORPORATION | SPIKEVAX BIVALENT (ORIGINAL / OMICRON BA.4/5) | Human | Yes | SCHEDULE D | 2 | ELASOMERAN | 0.05 MG / ML |
Application information
Related information
Contact us
Version 4.0.3